We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
-3.06%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$77.7B
AUM Growth
-$3.9B
(-4.8%)
Cap. Flow
+$505M
Cap. Flow
% of AUM
0.65%
Top 10 Holdings %
Top 10 Hldgs %
24.09%
Holding
3,066
New
55
Increased
1,481
Reduced
1,461
Closed
51
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$83.5M |
| 2 |
S&P Global
SPGI
|
+$73.5M |
| 3 |
Tesla
TSLA
|
+$55.8M |
| 4 |
Microsoft
MSFT
|
+$45.9M |
| 5 |
Amazon
AMZN
|
+$27.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
XLNX
Xilinx Inc
XLNX
|
+$88.8M |
| 2 |
INFO
IHS Markit Ltd. Common Shares
INFO
|
+$74.7M |
| 3 |
CONE
CyrusOne Inc Common Stock
CONE
|
+$31.7M |
| 4 |
Abbott
ABT
|
+$25.5M |
| 5 |
Exelon
EXC
|
+$23.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.74% |
| 2 | Financials | 13.53% |
| 3 | Healthcare | 13.01% |
| 4 | Consumer Discretionary | 11.66% |
| 5 | Industrials | 8.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
551
Synaptics
SYNA
$4.15B
| $21.4M | 0.03% |
107,133
+3,694
| +4% | +$819K |
|
|
SYNH
552
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| $21.1M | 0.03% |
261,225
-4,948
| -2% | -$419K |
|
553
Casey's General Stores
CASY
$30.9B
| $21.1M | 0.03% |
106,655
-999
| -0.9% | -$188K |
|
|
ACC
554
DELISTED
American Campus Communities, Inc.
ACC
| $21.1M | 0.03% |
377,536
-6,773
| -2% | -$363K |
|
555
Charles River Laboratories
CRL
$12.8B
| $20.9M | 0.03% |
73,483
-12,085
| -14% | -$3.73M |
|
556
OGE Energy
OGE
$9.71B
| $20.9M | 0.03% |
511,432
-11,660
| -2% | -$442K |
|
557
Leidos
LDOS
$17.3B
| $20.9M | 0.03% |
193,068
+2,632
| +1% | +$254K |
|
558
Sun Communities
SUI
$14.7B
| $20.9M | 0.03% |
118,948
+3,396
| +3% | +$631K |
|
559
NOV
NOV
$7B
| $20.8M | 0.03% |
1,062,494
-4,306
| -0.4% | -$75.4K |
|
560
CACI
CACI
$14.2B
| $20.8M | 0.03% |
69,161
-716
| -1% | -$198K |
|
561
Churchill Downs
CHDN
$6.12B
| $20.8M | 0.03% |
187,542
-76
| -0% | -$8.36K |
|
562
Dentsply Sirona
XRAY
$2.43B
| $20.8M | 0.03% |
422,300
+6,919
| +2% | +$366K |
|
563
Trex
TREX
$5.01B
| $20.8M | 0.03% |
317,969
-28
| -0% | -$2.49K |
|
564
Genpact
G
$5.76B
| $20.8M | 0.03% |
477,418
-10,632
| -2% | -$493K |
|
565
Omega Healthcare
OHI
$14.7B
| $20.8M | 0.03% |
665,932
-11,827
| -2% | -$349K |
|
566
Envista
NVST
$4.52B
| $20.6M | 0.03% |
423,369
-3,942
| -0.9% | -$182K |
|
|
HZNP
567
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $20.6M | 0.03% |
195,888
-2,586
| -1% | -$252K |
|
568
United Therapeutics
UTHR
$23.1B
| $20.6M | 0.03% |
114,867
-3,840
| -3% | -$732K |
|
569
Nordson
NDSN
$17.3B
| $20.6M | 0.03% |
90,722
-58,499
| -39% | -$13.4M |
|
570
First American
FAF
$7.58B
| $20.6M | 0.03% |
317,424
-15,915
| -5% | -$1.13M |
|
|
CMA
571
DELISTED
Comerica
CMA
| $20.6M | 0.03% |
227,421
-12,408
| -5% | -$1.17M |
|
572
UGI
UGI
$7.33B
| $20.5M | 0.03% |
564,952
+10,572
| +2% | +$423K |
|
573
Palantir
PLTR
$413B
| $20.4M | 0.03% |
1,483,999
-82,716
| -5% | -$1.1M |
|
574
LKQ Corp
LKQ
$6.29B
| $20.3M | 0.03% |
447,705
+10,942
| +3% | +$560K |
|
|
JNPR
575
DELISTED
Juniper Networks
JNPR
| $20.3M | 0.03% |
546,408
-15,604
| -3% | -$536K |
|
Similar funds
VAM
RhumbLine Advisers's Q1 2022 Portfolio in Review
As of Q1 2022, RhumbLine Advisers held 3,066 positions worth $77.7B, down 4.8% from $81.6B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Trading was light in Q1 2022: portfolio turnover was 3.5%. RhumbLine Advisers opened 55 new positions and exited 51, leaving the 3,066-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 26% a quarter earlier, followed by Financials and Healthcare.
- RhumbLine Advisers's largest Q1 2022 buy was Constellation Energy: 528,261 shares worth $29.7M.
- RhumbLine Advisers added most to Advanced Micro Devices in Q1 2022, an estimated $83.5M increase.
- RhumbLine Advisers's biggest Q1 2022 reduction was Abbott, cutting an estimated $25.5M.
- RhumbLine Advisers fully exited Xilinx Inc in Q1 2022, selling an estimated $88.8M.
- RhumbLine Advisers's ten largest holdings make up 24% of its $77.7B portfolio in Q1 2022.
- RhumbLine Advisers opened 55 new positions and closed 51 in Q1 2022.
- RhumbLine Advisers's portfolio value fell 4.8% quarter-over-quarter to $77.7B.
Based on RhumbLine Advisers's 13F filing for Q1 2022, filed 12 May 2022.